Type I arginine methyltransferases are intervention points to unveil the oncogenic Epstein-Barr virus to the immune system.
Ontology highlight
ABSTRACT: The oncogenic Epstein-Barr virus (EBV) evades the immune system but has an Achilles heel: its genome maintenance protein EBNA1. Indeed, EBNA1 is essential for viral genome maintenance but is also highly antigenic. Hence, EBV seemingly evolved a system in which the glycine-alanine repeat (GAr) of EBNA1 limits the translation of its own mRNA to the minimal level to ensure its essential function, thereby, at the same time, minimizing immune recognition. Therefore, defining intervention points at which to interfere with GAr-based inhibition of translation is an important step to trigger an immune response against EBV-carrying cancers. The host protein nucleolin (NCL) plays a critical role in this process via a direct interaction with G-quadruplexes (G4) formed in the GAr-encoding sequence of t
SUBMITTER: Angrand G
PROVIDER: S-EPMC9723642 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA